The Fluconazole 1%/Itraconazole 1% Topical Nail Liquid is a specialized antifungal medication designed for direct application to the nails. This dual-agent formulation combines the potent antifungal properties of fluconazole and itraconazole, each at a concentration of 1%, to effectively treat nail fungal infections, also known as onychomycosis. The liquid formulation is easy to apply and is intended to penetrate the nail bed, providing relief from the infection and its symptoms, which may include nail brittleness, discoloration, and thickening. By delivering the medication directly to the affected area, this topical solution promotes healthy nail regrowth and helps restore the natural appearance of the nails.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Fluconazole 1%/Itraconazole 1% Topical Nail Liquid is a specially compounded medication designed for direct application to the nails. This liquid formulation combines two potent antifungal agents, fluconazole and itraconazole, each at a concentration of 1%. These active ingredients are well-known for their efficacy in treating fungal infections of the nails, a condition medically referred to as onychomycosis. By delivering the medication topically, the formulation aims to maximize local drug concentration at the site of infection while minimizing systemic absorption and potential side effects.
The dual-action of fluconazole and itraconazole works synergistically to inhibit the growth of a wide range of fungi by disrupting the synthesis of the fungal cell membrane. Fluconazole primarily targets the enzyme lanosterol 14-α-demethylase, while itraconazole has a broader spectrum of action, affecting various cytochrome P450 enzymes involved in fungal ergosterol synthesis. This disruption leads to increased membrane permeability and ultimately the death of the fungal cells. The topical application ensures that the medication penetrates the hard keratin of the nails, which is essential for treating nail fungal infections effectively.
Patients with onychomycosis often experience nail discoloration, thickening, and brittleness, which can be distressing and may lead to pain or difficulty with walking. The Fluconazole 1%/Itraconazole 1% Topical Nail Liquid formulation is designed to address these symptoms by eradicating the fungal infection and promoting the growth of healthy nails. Regular application as directed by a healthcare provider can lead to gradual improvement in the appearance and integrity of the nails over time.
For prescribers considering this formulation for their patients, it is important to note that treatment duration may vary depending on the extent of the infection and the rate of nail growth. Patients should be advised to maintain consistency in application and follow-up with their healthcare provider to monitor the effectiveness of the treatment and make any necessary adjustments. As with any medication, potential side effects or drug interactions should be considered, and the formulation should be used with caution in patients with known sensitivities or contraindications to the active ingredients.
If you have any questions or require further information about the Fluconazole 1%/Itraconazole 1% Topical Nail Liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of this specialized medication.
The Fluconazole 1%/Itraconazole 1% Topical Nail Liquid is a specialized formulation intended for direct application to the nails. Both fluconazole and itraconazole are antifungal agents that work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. By disrupting the cell membrane, these medications effectively treat fungal infections of the nails, which can manifest as onychomycosis characterized by thickening, brittleness, and discoloration of the nail plate. This topical approach targets the site of infection, potentially reducing systemic absorption and side effects associated with oral antifungal treatments.
When considering drug interactions, it is important to note that systemic absorption of fluconazole and itraconazole from topical nail applications is expected to be minimal. However, if the patient is taking other medications that could potentially interact with azole antifungals, caution is advised. For instance, drugs that are metabolized by the cytochrome P450 enzyme system, particularly the CYP3A4 isoenzyme, may have altered effects when used concurrently with itraconazole or fluconazole. Examples include certain statins, calcium channel blockers, and immunosuppressants, among others. While the risk of systemic interaction is lower with topical application, patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements.
Additionally, patients should be advised to avoid using other topical products on the nails unless directed by a healthcare provider, as there may be potential interactions or incompatibilities that could affect the efficacy of the Fluconazole/Itraconazole nail liquid. For example, the use of other topical antifungals or nail cosmetic products simultaneously may alter the drug's absorption or adherence to the nail surface.
It is also important to consider the potential for allergic reactions or sensitivities to the active ingredients or excipients in the formulation. Patients with a known hypersensitivity to azole antifungals should not use this product. If signs of an allergic reaction occur, such as rash, itching, or irritation at the application site, use should be discontinued, and medical advice should be sought.
For prescribers and patients interested in using this formulation, it is crucial to review the patient's medication history for potential interactions and to monitor for any adverse effects or changes in the efficacy of concurrent medications. If you have any questions or require further information regarding the Fluconazole 1%/Itraconazole 1% Topical Nail Liquid, please reach out to us at Bayview Pharmacy for assistance.
The Fluconazole 1%/Itraconazole 1% Topical Nail Liquid is a specially compounded medication designed to treat fungal infections of the nails, a condition known as onychomycosis. This liquid formulation is applied directly to the affected nails, allowing for the active antifungal agents, fluconazole and itraconazole, to exert their effects locally with minimal systemic absorption. This targeted approach helps to maximize the drug concentration at the site of infection, which is essential for eradicating fungal pathogens that reside deep within the nail bed and nail plate.
Fluconazole is a triazole antifungal agent that works by inhibiting the fungal enzyme lanosterol 14-alpha-demethylase. This enzyme is crucial for converting lanosterol to ergosterol, an essential component of the fungal cell membrane. By disrupting ergosterol synthesis, fluconazole compromises the integrity of the fungal cell membrane, leading to cell death. Itraconazole, also a triazole, operates through a similar mechanism but has a broader spectrum of activity against various fungal organisms. The combination of fluconazole and itraconazole in this formulation provides a synergistic effect, enhancing the overall antifungal activity and increasing the likelihood of successful treatment.
When applied to the nails, the formulation is designed to penetrate the hard keratin structure of the nail plate, reaching the nail bed where the fungi reside. The liquid vehicle enhances the penetration of the active ingredients and maintains them in a solution form, which is critical for the diffusion through the dense nail tissue. Regular application as directed by a healthcare provider ensures that a consistent therapeutic level of the antifungal agents is maintained, which is necessary for the full eradication of the fungal infection.
In addition to treating fungal infections, the formulation may also improve other nail conditions such as brittleness and discoloration by reducing the fungal burden and allowing for the restoration of healthy nail tissue. Over time, with the resolution of the infection, patients may notice an improvement in the appearance and strength of their nails. It is important for patients to adhere to the treatment regimen and to follow up with their healthcare provider to monitor the progress of therapy.
For optimal results, patients should ensure that the nails are clean and dry before application and that the liquid is applied not only to the nail itself but also to the surrounding skin to address any potential area of infection. The unique properties of this compounded formulation require specific handling and storage conditions, so patients should follow the instructions provided by the pharmacy.
If you have any questions about the Fluconazole 1%/Itraconazole 1% Topical Nail Liquid, or if you would like more information on how this medication can be integrated into your treatment plan, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to both patients and prescribers to ensure the safe and appropriate use of this specialized medication.
This liquid is used primarily for treating fungal nail infections but also addresses issues like nail brittleness or discoloration. It delivers a combination of two antifungal agents, fluconazole and itraconazole, directly to the nail to promote healthy growth and improve nail appearance.
Clean the affected nail and dry thoroughly. Apply the liquid formulation directly onto the nail, preferably using the applicator provided, covering the entire nail surface, including the underside of the nail tip. It's important to follow your healthcare provider's instructions for application frequency and duration.
It's generally recommended to avoid nail polish or artificial nails during treatment to ensure the formulation has maximum contact with the nail. Consult with your healthcare provider regarding the use of any cosmetic products during treatment.
Results can vary depending on the severity and type of the nail condition. Some improvement might be noticeable within a few weeks, but fungal nail infections typically require several months of consistent treatment. Consult with your healthcare provider for a realistic timeline for your specific condition.
While this medication may be safe for use in various age groups, it's essential to consult with a healthcare provider before use, particularly in children and elderly patients whose nails may be more sensitive or who may have other health considerations.
If you miss a dose, apply the medication as soon as you remember. If it's almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not apply extra medication to make up for the missed dose.
Like all medications, this topical nail liquid can cause side effects, although not everyone gets them. Common side effects may include mild burning or irritation at the application site. If you experience severe or persistent side effects, contact your healthcare provider immediately.
The safety of this medication during pregnancy or breastfeeding has not been fully established. It is crucial to consult with your healthcare provider before using this product if you are pregnant, planning to become pregnant, or are breastfeeding.
Yes, this is a prescription medication. You will need to consult a healthcare provider to obtain a prescription and to ensure that it is the appropriate treatment for your nail condition.
Store the liquid formulation at room temperature away from direct sunlight and heat. Keep the bottle tightly closed when not in use. Ensure that it is kept out of reach of children and pets. Always check the expiration date before use and do not use if the product has expired.
Avoid contact with the eyes, mouth, or other mucous membranes. Do not apply to skin that is cut or irritated. Also, avoid using other topical products on the treated nails unless your healthcare provider has told you otherwise.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)